1. Home
  2. BEEM vs VERU Comparison

BEEM vs VERU Comparison

Compare BEEM & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.76

Market Cap

39.3M

Sector

Technology

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.10

Market Cap

40.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEEM
VERU
Founded
2006
1971
Country
United States
United States
Employees
220
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
40.9M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BEEM
VERU
Price
$1.76
$2.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$3.50
$22.50
AVG Volume (30 Days)
820.9K
54.1K
Earning Date
04-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$16,296,958.00
Revenue This Year
$40.48
N/A
Revenue Next Year
$32.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$0.36
52 Week High
$4.04
$4.59

Technical Indicators

Market Signals
Indicator
BEEM
VERU
Relative Strength Index (RSI) 48.85 37.44
Support Level $1.59 $0.36
Resistance Level $2.00 $2.67
Average True Range (ATR) 0.13 0.10
MACD -0.02 -0.01
Stochastic Oscillator 36.45 21.21

Price Performance

Historical Comparison
BEEM
VERU

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: